Legal5 Sept 2026, 05:20 pm
Zydus Pharma USA settles litigation for $5.9 million
AI Summary
Zydus Lifesciences Ltd announced that its wholly owned subsidiary, Zydus Pharmaceuticals USA Inc. (ZPUI), has entered into a Settlement Agreement with a putative class of Indirect Reseller Plaintiffs. This settlement resolves certain litigation matters pending in the United States District Court for the Eastern District of Pennsylvania, as part of MDL No. 2724. ZPUI has agreed to pay a total of USD 5.9 million to conclude these matters. The agreement includes a full and final release of all claims by the plaintiffs and was entered into without any admission of fault or wrongdoing by ZPUI.
Key Highlights
- Subsidiary ZPUI settles US litigation for $5.9 million.
- Settlement resolves antitrust litigation in Pennsylvania court.
- Agreement includes full release of claims by plaintiffs.
- No admission of fault or wrongdoing by ZPUI.
- Financial impact to be assessed based on cash outflow.
Price Impact
More from ZYDUSLIFE